Recurrence Clinical Trial
Official title:
Prospective Study to Visualize Dynamesh ® IPOM Visible Mesh With MRI After Laparoscopic Intraperitoneal Ventral Hernia Repair.
Purpose of the study is the visualization of the mesh and the determination of the mesh surface observed by MRI at 3 weeks and 13 months after ventral hernia repair with mesh visible IPOM (Dynamesh®). We want to prove that with this type of mesh it is possible to visualize the mesh position in vivo in a safe manner. This provides long-term benefit to early recognize possible recurrence caused by shifting or shrinking of the mesh and to provide early treatment.
INTRODUCTION:
The repair of ventral hernias always goes along with a discussion about placing the optimal
mesh, the optimum mesh position and the optimal fixation method of the mesh against the
abdominal wall. There are a lot of meshes available of different materials, in different
sizes and with different properties.
Penetrating fixation methods of the mesh have a strong positioning as result, but often at
the cost of increased acute postoperative pain. Less or non-permanent (absorbable) fixation
may decrease pain but should not risk a less stable mesh fixation ongoing with recurrence
due to mesh shifting of mesh shrinkage.
It is indeed known that the majority of implanted meshes do shrink to an extent, which may
be of disadvantage for the patient. This has already been demonstrated in several animal
studies, but clinical information on the mesh shrinkage is rare and mostly a result from
revised surgery.
All ordinary meshes for repair of abdominal hernia defects, based on polymeric textile, are
invisible to conventional imaging techniques, inclusive "magnetic resonance imaging" (MRI).
The IPOM mesh visible (Dynamesh®), developed by a unique method, contains an amount of iron
particles, woven in the ordinary structure of the mesh, which allows an imaging in the MRI.
This study aims to visualize the implanted mesh in vivo by MRI. Furthermore, in cooperation
with Dynamesh, we want to investigate the optimal concentration of iron particle resulting
in optimal MRI.
PURPOSE Purpose of the study is the visualization of the mesh and the determination of the
mesh surface observed by MRI at 3 weeks and 13 months after ventral hernia repair with mesh
visible IPOM (Dynamesh®). We want to prove that with this type of mesh it is possible to
visualize the mesh position in vivo in a safe manner. This provides long-term benefit to
early recognize possible recurrence caused by shifting or shrinking of the mesh and to
provide early treatment.
HERNIA REPAIR
- Introduction of the visible mesh IPOM (Dynamesh®) via laparoscopy and positioning
against the abdominal wall with a minimum overlap with the hernia defect of at least 5
cm in all directions.
- The mesh will be fixed with absorbable staples, Secure Traps (Ethicon, Johnson &
Johnson), in a double crown configuration. The staples are approximately 1.5 to 2 cm at
distant from each other.
- All patients receive a standardized pain treatment protocol. Analgesics used will be
checked. Visual analog scale (VAS) for pain will be measured at 4 hours, 8 hours, 12
hours, 16 hours, 20 hours and 24 hours post-operatively and every 12 hours thereafter
until discharge of the patient.
- Pain medication after discharge will be monitored and checked with the patient at each
consultation.
Clinical follow-up: clinical follow-up evaluations of patients at 1 and 13 months.
MRI measurement: post-operative scans and MRI analysis at 1 and 13 months.
DATA PROTECTION AND PRIVACY OF THE PATIENT All information about this study will be
collected in EuraHS registry. The data will be entered into the EuraHS platform with a coded
number, IMAP001, IMAP002, ...
LONG-TERM OUTCOME The ability to visualize the position of the intra-abdominal surgery mesh
on the abdominal wall in a secure manner would be a huge step in abdominal wall surgery. It
would give the surgeon the opportunity to quickly identify a possible loosening or moving or
shrinking of the prosthesis and thus to prevent recurrence and other long-term
complications.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03545659 -
Childhood Acute Lymphoblastic Leukaemia: Follow-Up
|
||
Completed |
NCT04838613 -
Study of Diagnostic Performance of [18F]CTT1057 in BCR
|
Phase 3 | |
Recruiting |
NCT05233020 -
Robotic Versus Hybrid Assisted Ventral Hernia Repair
|
N/A | |
Recruiting |
NCT04266600 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease
|
N/A | |
Recruiting |
NCT04539665 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.
|
N/A | |
Terminated |
NCT03257722 -
Pembrolizumab + Idelalisib for Lung Cancer Study
|
Phase 1/Phase 2 | |
Completed |
NCT01141335 -
Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia Repair
|
Phase 4 | |
Completed |
NCT00029185 -
Study of Dehydrex in Patients With Corneal Erosion
|
N/A | |
Completed |
NCT01351974 -
Sentinel Node Biopsy in Breast Cancer Patients
|
N/A | |
Not yet recruiting |
NCT06038422 -
GTP Regimen in the Treatment of Refractory/Recurrent HLH
|
Phase 3 | |
Withdrawn |
NCT03162120 -
Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation
|
Phase 2/Phase 3 | |
Recruiting |
NCT04159051 -
Charité HT-Prostate
|
N/A | |
Recruiting |
NCT02566928 -
Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
|
Phase 4 | |
Completed |
NCT01989845 -
Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer
|
Phase 4 | |
Recruiting |
NCT01229475 -
Stepwise Approach Versus Linear Ablation in Patients With Recurrence of Persistent Atrial Fibrillation
|
N/A | |
Completed |
NCT00944554 -
Relapse Prevention With Varenicline
|
Phase 4 | |
Terminated |
NCT02247258 -
Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.
|
Phase 2 | |
Completed |
NCT03654209 -
Post-resection Treatment of Large Colon Polyps
|
N/A | |
Recruiting |
NCT05557474 -
Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
|
||
Active, not recruiting |
NCT03865537 -
Cold Snare Endoscopic Mucosal Resection Trial
|
N/A |